BACKGROUND/AIMS: Thiazolidinediones (TZDs, like rosiglitazone (RGZ)) are peroxisome proliferator-activated receptor γ (PPARγ) agonists used to treat type 2 diabetes. Clinical limitations include TZD-induced fluid retention and body weight (BW) increase, which are inhibited by amiloride, an epithelial-sodium channel (ENaC) blocker. RGZ-induced fluid retention is maintained in mice with αENaC knockdown in the collecting duct (CD). Since ENaC in the connecting tubule (CNT) rather than in CD appears to be critical for normal NaCl retention, we aimed to further explore the role of ENaC in CNT in RGZ-induced fluid retention. METHODS: Mice with conditional inactivation of αENaC in both CNT and CD were used (αENaC lox/lox AQP2-Cre; 'αENaC-CNT/CD-KO') and compared with littermate controls (αENaC lox/lox mice; 'WT'). BW was monitored and total body water (TBW) and extracellular fluid volume (ECF) were determined by bioelectrical impedance spectroscopy (BIS) before and after RGZ (320 mg/kg diet for 10 days). RESULTS: On regular NaCl diet, αENaC-CNT/CD-KO had normal BW, TBW, ECF, hematocrit, and plasma Na(+), K(+), and creatinine, associated with an increase in plasma aldosterone compared with WT. Challenging αENaC-CNT/CD-KO with a low NaCl diet unmasked impaired NaCl and K homeostasis, consistent with effective knockdown of αENaC. In WT, RGZ increased BW (+6.1%), TBW (+8.4%) and ECF (+10%), consistent with fluid retention. These changes were significantly attenuated in αENaC-CNT/CD-KO (+3.4, 1.3, and 4.3%). CONCLUSION: Together with the previous studies, the current results are consistent with a role of αENaC in CNT in RGZ-induced fluid retention, which dovetails with the physiological relevance of ENaC in this segment.
BACKGROUND/AIMS: Thiazolidinediones (TZDs, like rosiglitazone (RGZ)) are peroxisome proliferator-activated receptor γ (PPARγ) agonists used to treat type 2 diabetes. Clinical limitations include TZD-induced fluid retention and body weight (BW) increase, which are inhibited by amiloride, an epithelial-sodium channel (ENaC) blocker. RGZ-induced fluid retention is maintained in mice with αENaC knockdown in the collecting duct (CD). Since ENaC in the connecting tubule (CNT) rather than in CD appears to be critical for normal NaCl retention, we aimed to further explore the role of ENaC in CNT in RGZ-induced fluid retention. METHODS:Mice with conditional inactivation of αENaC in both CNT and CD were used (αENaClox/loxAQP2-Cre; 'αENaC-CNT/CD-KO') and compared with littermate controls (αENaClox/loxmice; 'WT'). BW was monitored and total body water (TBW) and extracellular fluid volume (ECF) were determined by bioelectrical impedance spectroscopy (BIS) before and after RGZ (320 mg/kg diet for 10 days). RESULTS: On regular NaCl diet, αENaC-CNT/CD-KO had normal BW, TBW, ECF, hematocrit, and plasma Na(+), K(+), and creatinine, associated with an increase in plasma aldosterone compared with WT. Challenging αENaC-CNT/CD-KO with a low NaCl diet unmasked impaired NaCl and K homeostasis, consistent with effective knockdown of αENaC. In WT, RGZ increased BW (+6.1%), TBW (+8.4%) and ECF (+10%), consistent with fluid retention. These changes were significantly attenuated in αENaC-CNT/CD-KO (+3.4, 1.3, and 4.3%). CONCLUSION: Together with the previous studies, the current results are consistent with a role of αENaC in CNT in RGZ-induced fluid retention, which dovetails with the physiological relevance of ENaC in this segment.
Authors: Richard W Nesto; David Bell; Robert O Bonow; Vivian Fonseca; Scott M Grundy; Edward S Horton; Martin Le Winter; Daniel Porte; Clay F Semenkovich; Sidney Smith; Lawrence H Young; Richard Kahn Journal: Circulation Date: 2003-12-09 Impact factor: 29.690
Authors: Baichun Yang; Lisa G Clifton; Judi A McNulty; Lihong Chen; Kathleen K Brown; Philip G Baer Journal: J Cardiovasc Pharmacol Date: 2003-09 Impact factor: 3.105
Authors: Jian Song; Mark A Knepper; Xinqun Hu; Joseph G Verbalis; Carolyn A Ecelbarger Journal: J Pharmacol Exp Ther Date: 2003-10-30 Impact factor: 4.030
Authors: Isabelle Rubera; Johannes Loffing; Lawrence G Palmer; Gustavo Frindt; Nicole Fowler-Jaeger; Daniel Sauter; Tom Carroll; Andrew McMahon; Edith Hummler; Bernard C Rossier Journal: J Clin Invest Date: 2003-08 Impact factor: 14.808
Authors: David Mordasini; Dominique Loffing-Cueni; Johannes Loffing; Rohrbach Beatrice; Marc P Maillard; Edith Hummler; Michel Burnier; Geneviève Escher; Bruno Vogt Journal: Pflugers Arch Date: 2015-06-10 Impact factor: 3.657
Authors: Wei-Jie Wang; Chia-Sung Wang; Chi-Kang Wang; An-Ming Yang; Chien-Yu Lin Journal: Int J Environ Res Public Health Date: 2022-06-07 Impact factor: 4.614
Authors: Richard G Peterson; Charles Van Jackson; Karen M Zimmerman; Jorge Alsina-Fernandez; M Dodson Michael; Paul J Emmerson; Tamer Coskun Journal: PLoS One Date: 2017-06-22 Impact factor: 3.240